Oliver Rolf Baumann
CIK: 0002129436
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRXA
Veraxa Biotech Holding AG
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Baumann Oliver Rolf
Baumann Oliver Rolf (SEC CIK 0002129436) files insider reports with the SEC as Director of Veraxa Biotech Holding AG (VRXA).
Signal8 holds 1 ownership filing by Baumann Oliver Rolf, a Form 3, filed on Jun 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Baumann Oliver Rolf's filings is in ZURICH.
Other insiders filing for Veraxa Biotech Holding AG (VRXA)
- Gruninger Marc, Director
- Ziegler Christoph Samuel, Director
- Hosseinion Warren, Director
- Willener Raju Sudir, Chief Financial Officer
- von Halem Carl, Interim CFO
- Antz Christoph Rudiger, Chief Executive Officer